Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:35 pm Sale | 2025-03-31 | 13G | Evaxion Biotech A/S EVAX | ARMISTICE CAPITAL LLC | 310,441 4.990% | -328,888 (-51.44%) | Filing History |
| 2025-05-15 3:35 pm Purchase | 2025-03-31 | 13G | Edible Garden AG Incorporated EDBL | ARMISTICE CAPITAL LLC | 75,458 4.990% | 75,458 (New Position) | Filing History |
| 2025-05-15 3:34 pm Sale | 2025-03-31 | 13G | Draganfly Inc. DPRO | ARMISTICE CAPITAL LLC | 285,072 4.990% | -195,722 (-40.71%) | Filing History |
| 2025-05-15 3:34 pm Sale | 2025-03-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 4,362,572 4.990% | -853,873 (-16.37%) | Filing History |
| 2025-05-15 3:33 pm Sale | 2025-03-31 | 13G | BioXcel Therapeutics, Inc. BTAI | ARMISTICE CAPITAL LLC | 288,131 4.990% | -4,709,144 (-94.23%) | Filing History |
| 2025-05-15 3:33 pm Sale | 2025-03-31 | 13G | Bio-Path Holdings, Inc. BPTH | ARMISTICE CAPITAL LLC | 436,337 4.990% | -177,461 (-28.91%) | Filing History |
| 2025-05-15 3:33 pm Purchase | 2025-03-31 | 13G | Allurion Technologies Inc. ALUR | ARMISTICE CAPITAL LLC | 391,643 4.990% | 139,901 (+55.57%) | Filing History |
| 2025-05-15 3:31 pm Purchase | 2025-03-31 | 13G | NanoVibronix, Inc. NAOV | ARMISTICE CAPITAL LLC | 39,878 4.990% | 39,878 (New Position) | Filing History |
| 2025-05-15 3:31 pm Purchase | 2025-03-31 | 13G | Momentus Inc. MNTS | ARMISTICE CAPITAL LLC | 500,958 9.990% | 321,500 (+179.15%) | Filing History |
| 2025-05-15 3:31 pm Purchase | 2025-03-31 | 13G | MacroGenics, Inc. MGNX | ARMISTICE CAPITAL LLC | 6,296,000 9.980% | 20,000 (+0.32%) | Filing History |
| 2025-05-15 3:30 pm Purchase | 2025-03-31 | 13G | Moleculin Biotech, Inc. MBRX | ARMISTICE CAPITAL LLC | 1,250,000 8.930% | 910,233 (+267.90%) | Filing History |
| 2025-05-15 3:30 pm Purchase | 2025-03-31 | 13G | LM Funding America, Inc. LMFA | ARMISTICE CAPITAL LLC | 535,339 9.990% | 131,188 (+32.46%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | Presidio Property Trust, Inc. SQFT | ARMISTICE CAPITAL LLC | 157,092 9.990% | 81,440 (+107.65%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | Kura Oncology, Inc. KURA | ARMISTICE CAPITAL LLC | 6,572,000 7.590% | 772,000 (+13.31%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | ARMISTICE CAPITAL LLC | 13,700,000 8.470% | 4,232,000 (+44.70%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | SuperCom Ltd. SPCB | ARMISTICE CAPITAL LLC | 441,692 9.990% | 441,692 (New Position) | Filing History |
| 2025-05-15 3:28 pm Sale | 2025-03-31 | 13G | Intensity Therapeutics, Inc. INTS | ARMISTICE CAPITAL LLC | 872,547 5.750% | -254,321 (-22.57%) | Filing History |
| 2025-05-15 3:28 pm Unchanged | 2025-03-31 | 13G | Globus Maritime Limited GLBS | ARMISTICE CAPITAL LLC | 1,200,000 5.510% | 0 (Unchanged) | Filing History |
| 2025-05-15 3:28 pm Purchase | 2025-03-31 | 13G | Stardust Power Inc. SDST | ARMISTICE CAPITAL LLC | 4,526,000 8.200% | 4,526,000 (New Position) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | PDS Biotechnology Corporation PDSB | ARMISTICE CAPITAL LLC | 4,547,925 9.990% | 4,547,925 (New Position) | Filing History |